Harbor Capital Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.43M Sell
10,250
-2,102
-17% -$2.13M 0.76% 18
2025
Q4
$13.3M Sell
12,352
-18
-0.1% -$17.2K 1.03% 11
2025
Q3
$9.44M Buy
12,370
+335
+3% +$249K 0.73% 16
2025
Q2
$9.38M Sell
12,035
-70
-0.6% -$54.4K 0.39% 73
2025
Q1
$10M Sell
12,105
-2,951
-20% -$2.46M 0.46% 47
2024
Q4
$11.6M Buy
15,056
+92
+0.6% +$76.2K 0.51% 51
2024
Q3
$13.3M Sell
14,964
-14
-0.1% -$12.6K 0.58% 31
2024
Q2
$13.6M Buy
14,978
+119
+0.8% +$95.2K 1.03% 7
2024
Q1
$11.6M Sell
14,859
-482
-3% -$343K 1.51% 7
2023
Q4
$8.94M Sell
15,341
-429
-3% -$250K 1.72% 8
2023
Q3
$8.47M Sell
15,770
-783
-5% -$403K 1.81% 7
2023
Q2
$7.76M Sell
16,553
-21
-0.1% -$8.81K 1.55% 9
2023
Q1
$5.69M Buy
16,574
+14,564
+725% +$4.91M 1.64% 12
2022
Q4
$735K Sell
2,010
-43
-2% -$15.2K 0.71% 51
2022
Q3
$664K Buy
+2,053
New +$650K 0.61% 53

Other funds holding LLY

Harbor Capital Advisors's LLY Position: Q1 2026 in Review

Harbor Capital Advisors reduced its Eli Lilly (LLY) stake by 17% in Q1 2026, selling an estimated $2.13M and leaving 10,250 shares worth $9.43M. The position accounts for 0.76% of the portfolio, ranked #18.

Harbor Capital Advisors first reported a position in LLY in Q3 2022 and has held it in 15 quarters since. The position peaked at $13.6M in Q2 2024. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Harbor Capital Advisors held 10,250 shares of Eli Lilly worth $9.43M as of Q1 2026.
  • Harbor Capital Advisors sold 2,102 Eli Lilly shares in Q1 2026, an estimated $2.13M.
  • Eli Lilly made up 0.76% of Harbor Capital Advisors's portfolio in Q1 2026, its #18 holding.
  • Harbor Capital Advisors first reported a position in Eli Lilly in Q3 2022 and has held it in 15 quarters since.
  • Harbor Capital Advisors's Eli Lilly position peaked at $13.6M in Q2 2024.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Harbor Capital Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.